1. Home
  2. SDGR vs AZTA Comparison

SDGR vs AZTA Comparison

Compare SDGR & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

N/A

Current Price

$30.46

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Azenta Inc.

AZTA

Azenta Inc.

N/A

Current Price

$34.48

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SDGR
AZTA
Founded
1990
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
SDGR
AZTA
Price
$30.46
$34.48
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$21.43
★ $35.25
AVG Volume (30 Days)
★ 2.0M
641.1K
Earning Date
11-04-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.14
N/A
EPS
★ N/A
N/A
Revenue
$255,869,000.00
★ $593,821,000.00
Revenue This Year
N/A
$3.59
Revenue Next Year
$3.12
$4.26
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 23.29
N/A
52 Week Low
$10.95
$15.93
52 Week High
$31.59
$41.73

Technical Indicators

Market Signals
Indicator
SDGR
AZTA
Relative Strength Index (RSI) 73.76 62.75
Support Level $11.27 $32.40
Resistance Level $31.59 $37.49
Average True Range (ATR) 2.33 1.08
MACD 0.28 0.12
Stochastic Oscillator 90.69 88.33

Price Performance

Historical Comparison
SDGR
AZTA

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

Share on Social Networks: